TY - JOUR
T1 - Hippocampal and Insular Response to Smoking-Related Environments
T2 - Neuroimaging Evidence for Drug-Context Effects in Nicotine Dependence
AU - McClernon, F. Joseph
AU - Conklin, Cynthia A.
AU - Kozink, Rachel V.
AU - Adcock, R. Alison
AU - Sweitzer, Maggie M.
AU - Addicott, Merideth A.
AU - Chou, Ying Hui
AU - Chen, Nan Kuei
AU - Hallyburton, Matthew B.
AU - Devito, Anthony M.
N1 - Publisher Copyright:
© 2016 American College of Neuropsychopharmacology. All rights reserved.
PY - 2016/2/1
Y1 - 2016/2/1
N2 - Environments associated with prior drug use provoke craving and drug taking, and set the stage for lapse/relapse. Although the neurobehavioral bases of environment-induced drug taking have been investigated with animal models, the influence of drug-environments on brain function and behavior in clinical populations of substance users is largely unexplored. Adult smokers (n=40) photographed locations personally associated with smoking (personal smoking environments; PSEs) or personal nonsmoking environment (PNEs). Following 24-h abstinence, participants underwent fMRI scanning while viewing PSEs, PNEs, standard smoking and nonsmoking environments, as well as proximal smoking (eg, lit cigarette) and nonsmoking (eg, pencil) cues. Finally, in two separate sessions following 6-h abstinence they viewed either PSEs or PNEs while cue-induced self-reported craving and smoking behavior were assessed. Viewing PSEs increased blood oxygen level-dependent signal in right posterior hippocampus (pHPC; F 2,685 =3.74, p<0.024) and bilateral insula (left: F 2,685 =6.87, p=0.0011; right: F 2,685 =5.34, p=0.005). In the laboratory, viewing PSEs, compared with PNEs, was associated with higher craving levels (F 2,180 =18.32, p<0.0001) and greater ad lib smoking (F 1,36 =5.01, p=0.032). The effect of PSEs (minus PNEs) on brain activation in right insula was positively correlated with the effect of PSEs (minus PNEs) on number of puffs taken from a cigarette (r=0.6, p=0.001). Our data, for the first time in humans, elucidates the neural mechanisms that mediate the effects of real-world drug-associated environments on drug taking behavior under conditions of drug abstinence. These findings establish targets for the development and evaluation of treatments seeking to reduce environment provoked relapse.
AB - Environments associated with prior drug use provoke craving and drug taking, and set the stage for lapse/relapse. Although the neurobehavioral bases of environment-induced drug taking have been investigated with animal models, the influence of drug-environments on brain function and behavior in clinical populations of substance users is largely unexplored. Adult smokers (n=40) photographed locations personally associated with smoking (personal smoking environments; PSEs) or personal nonsmoking environment (PNEs). Following 24-h abstinence, participants underwent fMRI scanning while viewing PSEs, PNEs, standard smoking and nonsmoking environments, as well as proximal smoking (eg, lit cigarette) and nonsmoking (eg, pencil) cues. Finally, in two separate sessions following 6-h abstinence they viewed either PSEs or PNEs while cue-induced self-reported craving and smoking behavior were assessed. Viewing PSEs increased blood oxygen level-dependent signal in right posterior hippocampus (pHPC; F 2,685 =3.74, p<0.024) and bilateral insula (left: F 2,685 =6.87, p=0.0011; right: F 2,685 =5.34, p=0.005). In the laboratory, viewing PSEs, compared with PNEs, was associated with higher craving levels (F 2,180 =18.32, p<0.0001) and greater ad lib smoking (F 1,36 =5.01, p=0.032). The effect of PSEs (minus PNEs) on brain activation in right insula was positively correlated with the effect of PSEs (minus PNEs) on number of puffs taken from a cigarette (r=0.6, p=0.001). Our data, for the first time in humans, elucidates the neural mechanisms that mediate the effects of real-world drug-associated environments on drug taking behavior under conditions of drug abstinence. These findings establish targets for the development and evaluation of treatments seeking to reduce environment provoked relapse.
UR - http://www.scopus.com/inward/record.url?scp=84953911757&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84953911757&partnerID=8YFLogxK
U2 - 10.1038/npp.2015.214
DO - 10.1038/npp.2015.214
M3 - Article
C2 - 26179147
AN - SCOPUS:84953911757
SN - 0893-133X
VL - 41
SP - 877
EP - 885
JO - Neuropsychopharmacology
JF - Neuropsychopharmacology
IS - 3
ER -